CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bayer Schering Pharma AG v. Teva Pharmaceuticals USA Inc.

1:10-cv-00616

Overview

Case Number 1:10-cv-00616
Filing Date 2010-07-20
Status Terminated
Termination Date 2011-11-21
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceuticals Industries Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Bayer Schering Pharma AG Operating Company

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

Morris, Nichols, Arsht & Tunnell, 1201 North Market Street

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Bayer HealthCare Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

Morris, Nichols, Arsht & Tunnell, 1201 North Market Street

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Schering Corporation NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

Morris, Nichols, Arsht & Tunnell, 1201 North Market Street

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 13 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (13): πŸ‡©πŸ‡ͺ Germany πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7696206
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
Filed: 2009-09-29
Issued: 2010-04-13
Active (2.9 yrs remaining)
Expires: 2029-09-29

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME to answer complaint to August 26, 2010 - filed by Bayer HealthCare Pharmaceuticals Inc., Bayer Schering Pharma AG, Schering Cor...
Entry #7 • 2010-08-10 Document →

Docket Entries

(10 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-760620.) - filed by Bayer Schering Pharma AG, Bayer HealthCare Pharmaceuticals Inc., Schering Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(ksr) (Entered: 07/21/2010)

Entry #1 • 2010-07-20
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (ksr) (Entered: 07/21/2010)

Entry #2 • 2010-07-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,696,206 B2; (ksr) (Entered: 07/21/2010)

Entry #3 • 2010-07-20
1

Disclosure Statement pursuant to Rule 7.1 filed by Bayer HealthCare Pharmaceuticals Inc., Bayer Schering Pharma AG identifying Corporate Parent Bayer AG for Bayer HealthCare Pharmaceuticals Inc., Bayer Schering Pharma AG. (ksr) (Entered: 07/21/2010)

Entry #4 • 2010-07-20
1

Disclosure Statement pursuant to Rule 7.1 filed by Schering Corporation identifying Corporate Parent Merck & Co Inc. for Schering Corporation. (ksr) (Entered: 07/21/2010)

Entry #5 • 2010-07-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc